Nia Therapeutics, Inc. — Form D/A
Nia Therapeutics, Inc. of ALLSTON, MA, a company, filed a Form D amendment with the SEC on 2026-03-06. The offering totals $22.5M, of which $18.8M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2026-03-06
- Form: D/A
- Accession: 0001758725-26-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $22.5M
- Amount sold: $18.8M
- Remaining: $3.7M
- Minimum investment: $50K
- Investors: 33
- Date of first sale: 2021-12-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-427292
Issuer
- Name: Nia Therapeutics, Inc.
- CIK: 0001758725
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 119 BRAINTREE ST. UNIT 703, ALLSTON, MA, 02134
- Phone: 2675607402
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Larry Greenberg | Related Person | Allston, MA |
| Michael Kahana | Related Person | Allston, MA |
| Milton Morris | Related Person | Allston, MA |
| Daniel Rizzuto | Related Person | Allston, MA |
| Daniil Utin | Related Person | Allston, MA |
| Jonathan Wachter | Related Person | Allston, MA |
| Jonathan Wachter | Director | Allston, MA |
| Daniil Utin | Executive Officer | Allston, MA |
| Daniel Rizzuto | Director | Allston, MA |
| Daniel Rizzuto | Executive Officer | Allston, MA |
| Milton Morris | Director | Allston, MA |
| Larry Greenberg | Director | Allston, MA |
| Michael Kahana | Director | Allston, MA |
| Michael Kahana | Executive Officer | Allston, MA |
| Daniel Utin | Related Person | Allston, MA |
Other filings by this issuer (12)
More